Mucosal Healing in Celiac Disease: Villous Architecture and Immunohistochemical Features in Children on a Long-Term Gluten Free Diet.
gluten-free diet
immunohistochemistry
mucosal healing
villous architecture
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
07 Sep 2022
07 Sep 2022
Historique:
received:
21
07
2022
revised:
24
08
2022
accepted:
31
08
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
28
9
2022
Statut:
epublish
Résumé
Considerable heterogeneity exists across studies assessing intestinal mucosal recovery in celiac (CD) patients on a gluten-free diet (GFD). We aimed at investigating histological and immunohistochemical features in CD patients on a long-term GFD and to correlate them to the GFD duration. Morphometrical and immunohistochemical analysis were retrospectively performed on duodenal biopsies in three groups of children: 33 on a long-term (>2 years) GFD (GFD-group), four of which remained seropositive despite dietary adherence, 31 with villous atrophy (ACD-group) and 76 heathy, non-celiac (CTR-group). Moreover, in the GFD-group, we correlated immunohistochemical alterations to the GFD duration. The villous to crypt (V/C) ratio significantly improved after the GFD and completely normalized in all patients, becoming even higher than in the CTR-group (median value 3.2 vs. 3, p = 0.007). In parallel, the number of CD3+ and TCRγδ+ cells in the epithelium were significantly reduced in the GFD compared to ACD patients, even if they remained higher than in the CTR-group (p < 0.05). In contrast, CD25+ cells in the lamina propria significantly decreased after the GFD (p < 0.05) and become comparable to the CTR-group (p = 0.9). In the GFD-group there was no difference in the immunohistochemical parameters between seropositive and seronegative patients and alterations did not correlate to GFD length. In conclusion, a GFD is able to both restore a normal V/C ratio and reduce inflammation, but the epithelium maintains some stigmata of the disorder, such as an increased number of CD3+ and TCRγδ+ cells. These alterations persist regardless of the duration of the GFD.
Identifiants
pubmed: 36145072
pii: nu14183696
doi: 10.3390/nu14183696
pmc: PMC9504881
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Gastrointest Endosc. 2003 Feb;57(2):187-91
pubmed: 12556782
Rev Esp Enferm Dig. 2020 Feb;112(2):101-108
pubmed: 31880159
Annu Rev Immunol. 2011;29:493-525
pubmed: 21219178
Gastroenterology. 2015 Sep;149(3):681-91.e10
pubmed: 26001928
Am J Gastroenterol. 2003 Jun;98(6):1332-7
pubmed: 12818278
Clin Exp Immunol. 2014 Sep;177(3):611-7
pubmed: 24773630
Nutrients. 2018 Nov 18;10(11):
pubmed: 30453686
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):286-291
pubmed: 28112686
Semin Immunopathol. 2012 Jul;34(4):551-66
pubmed: 22660791
Nat Med. 2012 Feb 26;18(3):441-5
pubmed: 22366952
Cell. 2019 Feb 21;176(5):967-981.e19
pubmed: 30739797
J Pediatr Gastroenterol Nutr. 2017 Sep;65(3):267-269
pubmed: 28489675
J Clin Gastroenterol. 2019 Aug;53(7):507-513
pubmed: 29505551
Gastrointest Endosc. 2004 Jan;59(1):158-9; author reply 159-60
pubmed: 14740630
J Immunol. 2018 Jul 15;201(2):747-756
pubmed: 29884699
Adv Sci (Weinh). 2021 Jan 04;8(4):2003526
pubmed: 33643806
J Pediatr Gastroenterol Nutr. 2020 Jan;70(1):141-156
pubmed: 31568151
Am J Gastroenterol. 2012 Oct;107(10):1563-9
pubmed: 22825364
PLoS One. 2013 Oct 18;8(10):e76006
pubmed: 24204586
Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2
pubmed: 29551598
J Pediatr Gastroenterol Nutr. 2015 May;60(5):621-5
pubmed: 25514620
Nutrients. 2016 Aug 26;8(9):
pubmed: 27571100
Am J Gastroenterol. 2005 Oct;100(10):2294-8
pubmed: 16181383
Dig Dis Sci. 2011 Jul;56(7):2042-9
pubmed: 21221796
PLoS One. 2017 Nov 2;12(11):e0187526
pubmed: 29095937
Am J Gastroenterol. 2010 Jun;105(6):1412-20
pubmed: 20145607
Scand J Gastroenterol. 2011 Oct;46(10):1194-205
pubmed: 21843037
Scand J Gastroenterol. 2016 Dec;51(12):1439-1446
pubmed: 27534885
J Physiol Biochem. 2018 Feb;74(1):153-158
pubmed: 28815514
Cell Mol Gastroenterol Hepatol. 2021;11(1):13-32
pubmed: 32745639